The role of pathology in the identification of drug-induced hepatic toxicity

Expert Opinion on Drug Metabolism and Toxicology

Volumn 2, Issue 2, 2006, Pages 241-247

  Cullen, John M ^a   Miller, Richard T ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Drug induced toxicity; Liver; Pathology; Safety assessment; Toxicology

Indexed keywords

ACCURACY; CLINICAL PRACTICE; CLINICAL STUDY; DISEASE COURSE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LIVER TOXICITY; MORPHOLOGY; NONHUMAN; PATHOLOGIST; PROPHYLAXIS; REVIEW; SCIENTIST; ANIMAL; DRUG INDUSTRY; DRUG SCREENING; EDUCATION; HUMAN; LIVER; METHODOLOGY; PATHOLOGY; TOXIC HEPATITIS;

ANIMALIA;

ANIMALS; DRUG EVALUATION, PRECLINICAL; DRUG INDUSTRY; HEPATITIS, TOXIC; HUMANS; LIVER; PATHOLOGY, CLINICAL;

EID: 33847721500     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425255.2.2.241     Document Type: Review

References (18)

1. FARRELL GC, LIDDLE C: Hepatotoxicity in the twenty-first century. Semin. Liver Dis. (2002) 22(2):109-210. Overview of the current understanding of mechanisms of drug-induced hepatotoxicity.
2. GOODMAN ZD: Drug hepatotoxicity. Clin. Liver Dis. (2002) 6(2):381-397. Review of the pathology of drug-induced liver injury.
3. KLEINER D: Histopathology of drug-induced liver injury. Proceedings of Clinical Research Single Topic Conference: Drug Induced Liver Injury. Atlanta, USA (2005). An overview of the histological diagnosis of drug-induced liver injury.
4. LAZAROU J, POMERANZ BH, COREY PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA (1998) 279(15):1200-1205. An overview of the clinical problem of drug-induced toxicity.
5. LEE WM: Acute liver failure in the United States. Semin. Liver Dis. (2003) 23(3):217-226 A review of acute liver failure demonstrating the frequency of drug-induced toxicity.
6. ZIMMERMAN HJ: Expression of Hepatotoxicity. In: Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver. 2nd ed. HJ Zimmerman (Ed.), Lippincott Williams & Wilkins, Philadelphia, USA (1999):61-110. A definitive text on drug-induced liver toxicity.
7. DELEVE LD, SHULMAN HM, MCDONALD GB: Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-oclusive disease). Semin. Liver Dis. (2002) 22(1):27-42. An overview of the involvement of endothelial cells in hepatic toxicity.
8. LEVY C, LINDOR KD: Drug-induced cholestasis. Clin. Liver Dis. (2003) 7(2):7311-7330. Review of drug-induced liver injury that targets biliary excretion.
9. WATKINS PB: Idiosyncratic liver injury: challenges and approaches. Toxicol. Pathol. (2005) 33(1):1-5. An overview of idiosyncratic drug-induced liver injury.
10. BUGELSKI PJ: Genetic aspects of immune-mediated adverse drug effects. Nat. Rev. Drug Discov. (2005) 4(1):59-69. A review of the involvement of immune system in adverse drug effects.
11. OLSON H BETTON G, ROBINSON D et al.: Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul. Toxicol. Pharmacol. (2000) 32(1):56-67.
12. LEE WM: Drug-induced hepatotoxicity. N. Engl. J. Med. (2003) 349(5):474-485. Review of the mechanisms of drug-induced liver injury.
13. SCHWETZ BA: Toxicologic pathology: looking ahead. Toxicol. Pathol. (2003) 31(Suppl):2-5. An overview of the roles of pathologists and toxicologists in the future.
14. BURKHARDT JE, FLOYD E, KERLIN RL, ADLER RR, OCHOA R, REYNOLDS J: Commentary: a view on discovery pathology. Toxicol. Pathol. (1999) 27(4):472-473. Discussion of the interaction of traditional pathology and newer technologies in drug development.
15. VAN DER GREEF J, MCBURNEY RN: Innovation: rescuing drug discovery: in vivo systems pathology and systems pharmacology. Nat. Rev. Drug Discov. (2005) 4(12):961-967. An overview of the interactions between animal studies and novel technologies.
16. DANAN G, BENICHOU C: Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J. Clin. Epidemiol. (1993) 46(11):1323-1330. A description of a frequendy used causality assessment method for hepatotoxic drug reactions.
17. AITHAL GP, RAWLINS MD, DAY CP: Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J. Hepatol. (2000) 33(6):949-952. A description of an alternative causality assessment method for hepatotoxic drug reactions.
18. http://dilin.dcri.duke.edu